Real-world experience of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B: a retrospective study.

Pei-Yuan SuWei-Wen SuYu-Chun HsuSiou-Ping Huang Hsu-Heng Yen

Published in: PeerJ (2021)

Our study showed that switching to TAF from TDF had good antiviral effectiveness and stabilized renal function. The body weight and BMI decreased during TDF therapy and regained after switching to TAF.

Keyphrases

body weight
randomized controlled trial
hepatitis b virus
antiretroviral therapy
stem cells
physical activity
bone marrow
cell therapy
weight loss